Epigenome editing in cancer: Advances and challenges for potential therapeutic options

Authors:

Abstract
No abstract available
Funding Information
  • Knight Cancer Institute, Oregon Health and Science University (2018-CRUK-OHSU-001)
  • Misophonia Research Fund (GCNCR1042A)
  • Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health and Science University